{"slug":"community-research","tag":"community-research","variants":["community-research"],"description":"No description yet","count":1,"kinds":{"person":1},"related":[{"slug":"car-t","tag":"car-t","shared":1},{"slug":"myeloma","tag":"myeloma","shared":1}],"records":[{"id":"jesus-berdeja","kind":"person","name":"Jesús G. Berdeja","route":"/people/jesus-berdeja/","tldr":"Led CARTITUDE-1, the trial that brought ciltacabtagene autoleucel, the most active myeloma CAR-T, to approval."}]}